<DOC>
	<DOC>NCT00817505</DOC>
	<brief_summary>To evaluate the bioavailability of a tablet of AZD1656.</brief_summary>
	<brief_title>To Evaluate the Bioavailability of a Tablet of AZD1656</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Male or female, type I diabetes patients, female with non childbearing potential. Treated with insulin for more than 3 years. Well controlled HbA1c. Have a body mass index (BMI) ≥19 and ≤35 Clinically significant illness except type I diabetes, or clinically relevant trauma, as judged by the investigator, within 2 weeks before the first administration of the investigational product Daily use of nicotine containing substances.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Type I diabetes</keyword>
	<keyword>bioavailability</keyword>
</DOC>